TY - JOUR
T1 - Genetic Evaluation of the Child With Intellectual Disability or Global Developmental Delay
T2 - Clinical Report
AU - Council on Genetics
AU - Rodan, Lance H.
AU - Stoler, Joan
AU - Chen, Emily
AU - Geleske, Timothy
AU - Vergano, Samantha
AU - Holm, Ingrid A.
AU - Jones, Kelly
AU - Kalish, Jennifer
AU - Monteil, Danielle C.
AU - Pritchard, Amanda Barone
AU - Rasmussen, Sonja A.
AU - Russell, Bianca
AU - Santoro, Stephanie L.
AU - Trapane, Pamela
AU - Weaver, Kathryn Nicole
N1 - Publisher Copyright:
Copyright © 2025 by the American Academy of Pediatrics.
PY - 2025/7
Y1 - 2025/7
N2 - Genetic neurodevelopmental disorders are common in the pediatric population, and establishing a specific diagnosis early provides multiple benefits including prognostication, surveillance for disorder-related complications, accurate recurrence risk, and specific management. This report provides an approach to the genetic evaluation of developmental delay/intellectual disability for the general pediatrician. When possible, genetic testing should be selected by phenotype, and typical distinguishing clinical features to facilitate this are presented. If a specific disorder or group of disorders cannot be ascertained by phenotype, an agnostic (or hypothesis-free) approach is utilized. Recommendations are provided for this agnostic approach based on diagnostic yield and also practical considerations such as test complexity and impact on management. The general guidance in this report for genetic testing does not preclude further evaluation by relevant subspecialists as necessary, including neurologists, developmental pediatricians, and clinical geneticists.
AB - Genetic neurodevelopmental disorders are common in the pediatric population, and establishing a specific diagnosis early provides multiple benefits including prognostication, surveillance for disorder-related complications, accurate recurrence risk, and specific management. This report provides an approach to the genetic evaluation of developmental delay/intellectual disability for the general pediatrician. When possible, genetic testing should be selected by phenotype, and typical distinguishing clinical features to facilitate this are presented. If a specific disorder or group of disorders cannot be ascertained by phenotype, an agnostic (or hypothesis-free) approach is utilized. Recommendations are provided for this agnostic approach based on diagnostic yield and also practical considerations such as test complexity and impact on management. The general guidance in this report for genetic testing does not preclude further evaluation by relevant subspecialists as necessary, including neurologists, developmental pediatricians, and clinical geneticists.
UR - https://www.scopus.com/pages/publications/105010268771
U2 - 10.1542/peds.2025-072219
DO - 10.1542/peds.2025-072219
M3 - Article
C2 - 40545261
AN - SCOPUS:105010268771
SN - 0031-4005
VL - 156
JO - Pediatrics
JF - Pediatrics
IS - 1
M1 - e2025072219
ER -